| Product Code: ETC12463469 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iran Imatinib Drug Market Overview |
3.1 Iran Country Macro Economic Indicators |
3.2 Iran Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Iran Imatinib Drug Market - Industry Life Cycle |
3.4 Iran Imatinib Drug Market - Porter's Five Forces |
3.5 Iran Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Iran Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Iran Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Iran Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Iran Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Iran Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST) in Iran |
4.2.2 Rising awareness and diagnosis rates of these diseases leading to higher demand for imatinib drug |
4.2.3 Favorable government initiatives and policies supporting the healthcare sector in Iran |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products in Iran |
4.3.2 Lack of access to advanced healthcare facilities in certain regions of the country |
4.3.3 Price sensitivity of patients due to economic conditions in Iran |
5 Iran Imatinib Drug Market Trends |
6 Iran Imatinib Drug Market, By Types |
6.1 Iran Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Iran Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Iran Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Iran Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Iran Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Iran Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Iran Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Iran Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Iran Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Iran Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Iran Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Iran Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Iran Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Iran Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Iran Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Iran Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Iran Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Iran Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Iran Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Iran Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Iran Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Iran Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Iran Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Iran Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Iran Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Iran Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Iran Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Iran Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Iran Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Iran Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Iran Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Iran Imatinib Drug Market Import-Export Trade Statistics |
7.1 Iran Imatinib Drug Market Export to Major Countries |
7.2 Iran Imatinib Drug Market Imports from Major Countries |
8 Iran Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib therapy |
8.2 Number of new diagnosed cases of CML and GIST in Iran |
8.3 Rate of prescription of imatinib by healthcare providers |
8.4 Number of clinical trials and research studies on imatinib conducted in Iran |
8.5 Patient satisfaction and feedback on the availability and affordability of imatinib |
9 Iran Imatinib Drug Market - Opportunity Assessment |
9.1 Iran Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Iran Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Iran Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Iran Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Iran Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Iran Imatinib Drug Market - Competitive Landscape |
10.1 Iran Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Iran Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here